Zymeworks Inc. (ZYME) Financial Statements
Zymeworks Inc. (ZYME) reported trailing twelve-month revenue of $37.1M (down 69.8% year on year) and net income of -$150.0M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$120.5M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ZYMEZymeworks Inc.Follow ZYME — free
—
Price chart with a free account
- Market cap
- 2.0B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|
| Revenue | 412.5 | 76.0 | 76.3 | 106.0 | 37.1 | |
| Research & development | 208.6 | 143.6 | 134.6 | 137.0 | 128.7 | |
| Operating income | 130.5 | -138.1 | -137.1 | -92.5 | -155.6 | |
| Pre-tax income | 135.2 | -119.2 | -116.6 | -79.8 | -151.4 | |
| Income tax | 10.9 | -0.6 | 6.1 | 1.4 | -1.4 | |
| Net income | 124.3 | -118.7 | -122.7 | -81.1 | -150.0 | |
| Diluted EPS ($) | 1.90 | -1.72 | -1.62 | -1.08 | -2.02 | |
| Diluted shares (mn) | 65.2 | 68.9 | 75.9 | 75.4 | — |
USD millions · SEC XBRL
Zymeworks Inc. — questions
- What is Zymeworks Inc.'s revenue?
- $37.1M over the twelve months to 2026-06-30, down 69.8% year on year, from its 10-Q and 10-K filings.
- What is Zymeworks Inc.'s net income?
- -$150.0M over the twelve months to 2026-06-30.
- What is Zymeworks Inc.'s free cash flow?
- -$120.5M over the twelve months to 2026-06-30.
- What are Zymeworks Inc.'s diluted earnings per share?
- $-2.02 over the twelve months to 2026-06-30.
Every figure on this page comes from Zymeworks Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.